Five Value Opportunities for 2026: PayPal (PYPL), Nike (NKE), HP (HPQ) and Others Worth Monitoring

Quick Overview

Table of Contents

PayPal (PYPL) projected stagnant adjusted earnings for 2026, triggering selloff despite potential turnaround opportunities
CVS Health (CVS) delivered $402.1 billion in 2025 annual revenue and projects minimum $400 billion for 2026
Nike (NKE) achieved $11.3 billion Q3 2026 revenue featuring 5% wholesale growth and North American expansion
HP (HPQ) generated Q1 2026 revenue of $14.4 billion representing 6.9% annual increase, maintaining $2.8–$3.0 billion free cash flow target
Estée Lauder (EL) stock declined following underwhelming fiscal 2026 outlook despite exceeding profit forecasts

Investors searching for mispriced opportunities in 2026 are closely examining PayPal, CVS Health, Nike, HP, and Estée Lauder.

These companies represent more than bargain-bin equities. They demonstrate a unified characteristic: negative market sentiment combined with tangible operational drivers that may transform their valuations on Wall Street.

Companies Pursuing Transformation

PayPal (PYPL)

PayPal exemplifies how subdued market expectations can create opportunity amid potential operational improvement. According to Reuters reporting in February, the digital payments giant projected essentially flat adjusted profitability for 2026, missing analyst projections.

PayPal Holdings, Inc., PYPL

Shares tumbled following management transitions that sparked concerns about strategic direction. However, successful enhancement of branded checkout experiences and deeper Venmo revenue generation could reposition the stock as a fintech recovery story.

CVS Health (CVS)

CVS Health remains attractively valued considering its operational scale. The healthcare giant posted 2025 annual revenue totaling $402.1 billion. Leadership provided 2026 adjusted earnings guidance between $7.00 and $7.20 per share, projecting minimum revenue of $400 billion.

CVS Health Corporation, CVS

Significant upside doesn’t require complete transformation. Modest profitability enhancement across insurance and pharmacy operations could prompt investors to recognize it as a sustainable cash-generating enterprise.

Nike (NKE)

Nike continues facing market skepticism about its complex operational challenges. The athletic apparel leader’s fiscal Q3 2026 results announced March 31 showed revenue reaching $11.3 billion with wholesale channels advancing 5%. The North American market also posted gains.

NIKE, Inc., NKE

Gross profitability contracted, and certain segments continue struggling. Nevertheless, selective operational improvements are emerging—precisely where value opportunities typically originate.

Free Cash Flow and Operational Recovery

HP (HPQ)

HP delivered fiscal Q1 2026 revenue totaling $14.4 billion, representing 6.9% year-over-year expansion. Adjusted diluted earnings per share climbed 9.5%, while free cash flow registered $175 million. Management reaffirmed annual free cash flow expectations between $2.8 billion and $3.0 billion.

The investment thesis centers on stabilizing PC market conditions and accelerating AI-enabled PC adoption. HP doesn’t require explosive top-line expansion—consistent profitability performance should drive appreciation.

Estée Lauder (EL)

Estée Lauder presents the greatest uncertainty among these five opportunities. Reuters reported in February that shares tumbled after fiscal 2026 projections disappointed investors, despite exceeding profit estimates.

Executives emphasized transformation through new product introductions, enhanced marketing initiatives, and luxury brand positioning. Markets remain concerned about sluggish domestic demand, tariff implications, and execution challenges.

Based on current guidance, Estée Lauder hasn’t yet demonstrated sustainable revenue expansion or margin improvement.

Concluding Analysis

These five equities share a fundamental commonality. Market sentiment remains cautious, yet each possesses legitimate operational catalysts that could fundamentally reshape their 2026 valuations.